Explore All Access
Check if your research matches the topics covered in Blood Cancer Journal?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Blood Cancer Journal : Impact Factor & More
eISSN: 2044-5385pISSN: 2044-5385
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Blood Cancer Journal Key Metrics
CiteScore 
11.8
Eigenfactor
0.01 - 0.05
Impact Factor
10 - 15
Scite Index
0.86 5-Year SI
SJR
Q1Oncology
SNIP
2.52
Time to Publish
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months37%
4 to 6 months51%
7 to 9 months10%
Above 9 months3%
Did you find this useful?
Topics Covered on Blood Cancer Journal
Amyloidosis
Proteasome
Overall survival
Plasma cell leukemia
Minimal residual disease
B-cell lymphoma
Functional validation
Diffuse large B-cell lymphoma
Monoclonal antibody
Lenalidomide
Immunotherapy
Daratumumab
Refractory Multiple Myeloma
Observational study
Monoclonal gammopathy of undetermined significance
Poor prognosis
Creatinine
Thrombosis
Genetic complexity
T-cell leukemia
Blood Cancer Journal Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | SPRINGERNATURE |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 3790 | USD 4790 | GBP 3290 |
| Publication Time | 14 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2011 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Blood Cancer Journal ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Blood Cancer Journal
Impact of TP53 mutation on genetic and cellular hierarchy profile in complex karyotype AML/MDS with increased blasts.
- 15 Nov 2024
- Blood cancer journal
Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry.
- 11 Nov 2024
- Blood cancer journal
Genetically determined telomere length in monoclonal gammopathy of undetermined significance, multiple myeloma risk and outcome.
- 11 Nov 2024
- Blood cancer journal
A simplified, two-factor clinical prognostic scoring system for patients with newly diagnosed Hodgkins Lymphoma.
- 11 Nov 2024
- Blood cancer journal
Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma
- 7 Nov 2024
- Blood Cancer Journal
Proteasome inhibitors related thrombotic microangiopathy: a systematic and comprehensive review
- 7 Nov 2024
- Blood Cancer Journal
Impact of TP53 mutation on genetic and cellular hierarchy profile in complex karyotype AML/MDS with increased blasts.
- 15 Nov 2024
- Blood cancer journal
Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry.
- 11 Nov 2024
- Blood cancer journal
Genetically determined telomere length in monoclonal gammopathy of undetermined significance, multiple myeloma risk and outcome.
- 11 Nov 2024
- Blood cancer journal
A simplified, two-factor clinical prognostic scoring system for patients with newly diagnosed Hodgkins Lymphoma.
- 11 Nov 2024
- Blood cancer journal
Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma
- 7 Nov 2024
- Blood Cancer Journal
Proteasome inhibitors related thrombotic microangiopathy: a systematic and comprehensive review
- 7 Nov 2024
- Blood Cancer Journal
Compare Similar Journals with Blood Cancer Journal
Select Journals to Compare with Blood Cancer Journal
Total journals - 8
You can select up to 3 Journals at a time
Blood
Publisher: AMER SOC HEMATOLOGY
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
British Journal of Haematology
Publisher: WILEY
Annals of Hematology
Publisher: SPRINGER
Blood advances
Publisher: ELSEVIER
American Journal of Hematology
Publisher: WILEY
Leukemia
Publisher: SPRINGERNATURE
Cancers
Publisher: MDPI
0 Journals Selected to compare with
Blood Cancer Journal
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Blood Cancer Journal
How long has Blood Cancer Journal been actively publishing? 
Blood Cancer Journal has been in operation since 2011 till date.
What is the publishing frequency of Blood Cancer Journal?
Blood Cancer Journal published with a Continuous publication frequency.
How many articles did Blood Cancer Journal publish last year?
In 2023, Blood Cancer Journal publsihed 194 articles.
What is the eISSN & pISSN for Blood Cancer Journal?
For Blood Cancer Journal, eISSN is 2044-5385 and pISSN is 2044-5385.
What is Citescore for Blood Cancer Journal?
Citescore for Blood Cancer Journal is 11.8.
What is SNIP score for Blood Cancer Journal?
SNIP score for Blood Cancer Journal is 2.52.
What is the SJR for Blood Cancer Journal?
SJR for Blood Cancer Journal is Q1.
Who is the publisher of Blood Cancer Journal?
SPRINGERNATURE is the publisher of Blood Cancer Journal.
